Chimin(SH:603222) Xin Lang Cai Jing·2026-02-26 01:39Group 1 - The core viewpoint of the news is that Jimin Health has experienced fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2]. - On February 25, Jimin Health's stock rose by 1.68%, with a trading volume of 75.77 million yuan. The net financing purchase was 211,300 yuan, with a total financing and margin balance of 169 million yuan [1]. - The financing balance of Jimin Health is 169 million yuan, accounting for 3.55% of its market capitalization, which is below the 20th percentile level over the past year, indicating a low financing level [1]. - In terms of short selling, Jimin Health had no shares repaid on February 25, with 300 shares sold short, amounting to 2,721 yuan. The short selling balance is 8,070 yuan, which is above the 80th percentile level over the past year, indicating a high level of short selling [1]. Group 2 - As of September 30, the number of shareholders of Jimin Health increased by 107% to 58,100, while the average circulating shares per person decreased by 51.69% to 9,035 shares [2]. - For the period from January to September 2025, Jimin Health reported a revenue of 545 million yuan, a year-on-year decrease of 20.21%. The net profit attributable to the parent company was -77.15 million yuan, a significant year-on-year decrease of 371.51% [2]. - Since its A-share listing, Jimin Health has distributed a total of 127 million yuan in dividends, with 10.74 million yuan distributed in the last three years [3].